Nanoparticles: New agents toward treatment of leishmaniasis

Leishmaniasis is a widespread disease that causes 20,000 to 30,000 deaths annually, making it a major health problem in endemic areas. Because of low-performance medications, drug delivery poses a great challenge for better treatment of leishmaniasis. The present study's purpose was to review t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nafari, Amir, Cheraghipour, Koroush, Sepahvand, Maryam, Shahrokhi, Ghazal, Gabal, Esraa, Mahmoudvand, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298521/
https://www.ncbi.nlm.nih.gov/pubmed/32566773
http://dx.doi.org/10.1016/j.parepi.2020.e00156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298521/
https://www.ncbi.nlm.nih.gov/pubmed/32566773
http://dx.doi.org/10.1016/j.parepi.2020.e00156

Ejemplares similares